90568-07-3Relevant articles and documents
Caserio,Graham,Roberts
, p. 171,177 (1960)
3-formamido-4-hydroxyl naltrexone deuterated derivative, preparation method thereof and application of 3-formamido-4-hydroxyl naltrexone deuterated derivative in medicine
-
Paragraph 0106; 0109-0112, (2021/08/14)
The invention relates to a 3-formamido-4-hydroxyl naltrexone deuterated derivative, a preparation method thereof and application of the 3-formamido-4-hydroxyl naltrexone deuterated derivative in medicine. In particular, the present invention relates to a 3-formamido-4-hydroxynaltrexone deuterated derivative represented by a general formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, and application of the 3-formamido-4-hydroxyl naltrexone deuterated derivative as an opioid receptor modulator in the treatment of cough, diarrhea, drug dependence, gastrointestinal tract diseases, allergic bowel syndrome, obesity, respiratory depression, convulsion, pain, allergy, pruritus and other diseases, and central nervous system diseases or/and mental diseases and other related diseases, wherein each substituent in the general formula (I) is as defined in the specification.
HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
-
Paragraph 0844, (2018/06/12)
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
